Patents by Inventor W. Jeffrey ALLARD

W. Jeffrey ALLARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
    Publication number: 20200292549
    Abstract: The disclosure relates to use of the HE4/HE4a marker(s) to assess endometrial and uterine cancer in a patient. The disclosure also relates to using tumors marks for diagnosis, grading and staging of endometrial and uterine cancers. The disclosure also relates to determining prognosis and treatment effectiveness of a patient who has been diagnosed with endometrial or uterine cancer.
    Type: Application
    Filed: February 4, 2020
    Publication date: September 17, 2020
    Applicant: FUJIREBIO DIAGNOSTICS, INC.
    Inventors: Richard MOORE, Elizabeth SOMERS, W. Jeffrey ALLARD
  • Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers
    Publication number: 20180180620
    Abstract: The disclosure relates to use of the HE4/HE4a marker(s) to assess endometrial and uterine cancer in a patient. The disclosure also relates to using tumors marks for diagnosis, grading and staging of endometrial and uterine cancers. The disclosure also relates to determining prognosis and treatment effectiveness of a patient who has been diagnosed with endometrial or uterine cancer.
    Type: Application
    Filed: February 14, 2018
    Publication date: June 28, 2018
    Applicant: FUJIREBIO AMERICA, INC.
    Inventors: Richard MOORE, Elizabeth SOMERS, W. Jeffrey ALLARD